A CLIA inspection (formally a "survey") is the on-site review CMS, a state survey agency acting on CMS’s behalf, or a CMS-approved accrediting organization conducts to confirm a laboratory’s testing meets the quality standards set out in 42 CFR Part 493. This page walks through who actually gets inspected, what a surveyor reviews once they’re on site, and a practical checklist for getting a lab ready. For background on certificate types, test-complexity categories, and whether a research lab is even in CLIA’s scope at all, start with CLIA Certification: Certificate Types, Complexity Categories, and Whether Your Lab Needs One — this page assumes a lab has already determined it holds, or needs, a certificate that carries a routine inspection requirement.
Which certificate types actually get a routine CLIA inspection
Not every CLIA-certified lab is inspected the same way, and some aren’t inspected on a routine basis at all:
- Certificate of Waiver — no routine on-site survey. Waived-testing labs are exempt from CLIA’s routine inspection and proficiency-testing enrollment requirements, though CMS or a state agency can still conduct a complaint-driven or validation visit, and deviating from a test’s labeled instructions can jeopardize waived status. See CLIA-Waived Point-of-Care Testing for detail on that certificate.
- Certificate for Provider-Performed Microscopy (PPM) — generally not subject to routine survey either, though a state agency retains authority to inspect for cause.
- Certificate of Registration — the interim certificate a lab holds while awaiting its initial compliance survey; the routine inspection is what converts this into a Certificate of Compliance.
- Certificate of Compliance — inspected directly by the state survey agency on CMS’s behalf, on a recurring cycle.
- Certificate of Accreditation — inspected instead by the lab’s chosen CMS-approved private accrediting organization (for example CAP, The Joint Commission, or COLA), whose standards CMS has determined meet or exceed CLIA’s own. CMS retains authority to conduct its own validation survey of an accredited lab, independent of the accreditor’s own inspection, as a check on the accreditation program itself.
In short: if a lab performs only waived testing, "CLIA inspection checklist" mostly isn’t a live concern beyond keeping documentation of following manufacturer instructions. If a lab performs moderate- or high-complexity testing, routine survey is a real, recurring event — either from the state or from an accreditor, not both as a matter of course.
How often, and announced or unannounced
Routine recertification surveys for moderate- and high-complexity testing run on a biennial (roughly every two years) cycle, aligned with the two-year certificate renewal period. Initial surveys happen before a Certificate of Registration converts to a Certificate of Compliance. Beyond the routine cycle, a lab can also be surveyed:
- For cause / complaint-driven — triggered by a complaint, a reported incident, or a pattern CMS or the state agency flags independently of the routine schedule.
- As a validation survey — CMS or the state agency re-surveying a lab that was already inspected and accredited by a private accrediting organization, to validate that the accreditor’s own process is working.
- As a resurvey — a follow-up visit specifically to confirm a previously cited deficiency has actually been corrected.
Routine CLIA surveys are generally unannounced — the lab does not get advance notice of the exact date. The practical implication is that "preparing for inspection" has to mean maintaining survey-ready documentation and practice continuously, not doing a scramble in the days before a known date.
What a surveyor actually reviews
A CLIA surveyor works through the lab against the CMS interpretive guidelines for laboratories, checking documentation and observing practice across several regulatory categories under 42 CFR Part 493. The core areas every moderate/high-complexity lab should expect to be asked about:
- Personnel qualifications and competency. Documentation that the laboratory director, technical supervisor, general supervisor, and testing personnel each meet the education/experience/certification minimums that apply to their role and to the complexity of testing performed, plus documented, ongoing competency assessment for each person performing testing — not just a hiring-time credential check.
- Quality control (QC). Evidence that QC is run at the required frequency for each test system, that QC results are reviewed and any out-of-range result triggers a documented corrective action before patient results are reported, and that QC records are retained per the applicable retention period.
- Proficiency testing (PT) enrollment and performance. Confirmation the lab is enrolled in an approved PT program for every regulated analyte it performs, that PT samples are tested the same way as patient specimens (not sent to a reference lab or otherwise handled differently), and that PT results and any corrective actions for unsuccessful performance are on file. See Proficiency Testing & External Quality Assessment (EQA) for Accredited Labs for the full mechanics of this requirement.
- Procedure manuals and test validation/verification. Current, approved written procedures for every test performed, plus documentation that each test system was properly validated (for high-complexity/lab-developed tests) or verified (for FDA-cleared moderate-complexity systems) before being placed into clinical use.
- Quality assessment / quality management program. A documented, active program that monitors and evaluates the quality of the total testing process — preanalytic, analytic, and postanalytic — and that generates and tracks corrective actions, not just a policy that exists on paper.
- Specimen handling and reporting. Specimen acceptance/rejection criteria, chain-of-custody where relevant, turnaround-time tracking, and a documented process for communicating critical/panic values.
- Equipment maintenance and calibration. Records showing instruments are maintained and calibration-verified on the manufacturer- or lab-defined schedule, not just that a calibration was performed once at installation.
- General laboratory systems documentation. Complaint logs, corrective-action logs, and records tying earlier problems to the fixes actually implemented — surveyors specifically look for evidence that a lab’s own quality system catches and closes its own issues, not just that a binder of policies exists.
Labs running high-complexity testing should expect deeper scrutiny of personnel qualification files (the credentialing tiers under 42 CFR 493 Subpart M are stricter for high complexity) and of test validation records specifically — see CLIA High-Complexity Testing Requirements for what that higher bar looks like in practice.
A practical pre-inspection checklist
Because routine surveys are unannounced, the goal is a lab that is inspection-ready year-round. Items worth confirming on a recurring basis, not just when a survey seems imminent:
- Personnel files are current for every individual performing or supervising testing, with documented competency assessment on the required schedule (commonly semiannual in the first year, then annual).
- QC logs for every test system are complete, with no gaps, and every out-of-range QC event has a linked, dated corrective action on file.
- PT enrollment covers every regulated analyte the lab actually performs, PT results for the most recent testing events are filed, and any unsuccessful PT event has a documented root-cause investigation and corrective action.
- Procedure manuals match what staff actually do at the bench — a common, easily-cited gap is a written procedure that was never updated after a reagent, instrument, or workflow change.
- Validation or verification records exist for every test system currently in use, including any recent method or lot changes.
- Equipment maintenance and calibration logs are current, with no missed intervals unexplained.
- The quality assessment program has recent, dated activity — not a policy binder with no entries in the last review period.
- Complaint and incident logs show follow-through to a documented resolution, not just an intake entry.
- Reagent and consumable lot records support traceability back to the vendor and lot-to-lot verification where required — see Supplier Audit and Vendor Qualification Process for how procurement-side documentation feeds into this.
- Certificates (CLIA certificate itself, and any relevant state licensure) are current and posted or readily producible.
What happens after the survey
If a surveyor identifies a deficiency, it is cited against the specific regulatory condition or standard under 42 CFR Part 493 that was not met. The lab receives a statement of deficiencies and is generally required to submit an acceptable plan of correction describing how and by when each deficiency will be resolved. Depending on severity:
- Standard-level deficiencies typically require a plan of correction and evidence of resolution, sometimes verified at the next routine survey rather than a dedicated resurvey.
- Condition-level deficiencies — more serious, indicating a whole regulatory condition (e.g., an entire quality-control or personnel requirement) isn’t met — can trigger a dedicated resurvey to confirm correction and, if uncorrected, can lead to sanctions.
- Situations posing immediate jeopardy to patient health or safety can result in immediate sanctions, including suspension or revocation of the certificate, independent of the normal correction timeline.
CMS sanctions for uncorrected or serious deficiencies range from alternative sanctions (such as a directed plan of correction, on-site monitoring, or civil money penalties) up to principal sanctions — suspension, limitation, or revocation of the CLIA certificate, which also ends the lab’s Medicare/Medicaid reimbursement eligibility for the affected testing.
CLIA survey vs. accreditation-body inspection
A lab holding a Certificate of Accreditation is not inspected directly by a state agency — it is inspected by its chosen accrediting organization (CAP, The Joint Commission, COLA, or another CMS-approved body) against that organization’s own standards, which CMS has determined meet or exceed CLIA’s. CAP’s laboratory accreditation program, for example, is built on checklists that go beyond CLIA’s minimums and layer in ISO/IEC 17025–adjacent quality-system concepts (clinical labs typically reference ISO 15189 rather than 17025, which is the general testing-and-calibration-lab standard, not a clinical-testing one). The practical effect for a lab choosing accreditation over direct state Compliance survey is consolidating CLIA compliance and broader laboratory accreditation into a single inspection cycle, generally with more detailed checklists than the bare CLIA regulatory minimum — which is one reason higher-volume clinical and translational-research labs performing moderate/high-complexity testing often choose it.
Frequently asked questions
Is a CLIA inspection announced in advance?
No. Routine CLIA recertification surveys are generally unannounced — the lab is not told the exact date ahead of time, which is why year-round documentation discipline matters more than pre-visit preparation.
How often does a lab get a CLIA inspection?
Labs holding a Certificate of Compliance or Certificate of Accreditation for moderate/high-complexity testing are on a routine cycle of roughly every two years, aligned with the certificate’s two-year renewal period. Labs can also be surveyed off-cycle for cause (a complaint or reported incident) or as a CMS validation survey of an already-accredited lab.
Do Certificate of Waiver labs get inspected?
Not on a routine basis. Waived testing is exempt from CLIA’s routine survey and proficiency-testing requirements, though a lab can still be visited for cause, and departing from a waived test’s labeled instructions puts that exemption at risk.
What are the most commonly cited CLIA deficiencies?
Personnel competency-assessment documentation, gaps in quality-control review and corrective action, incomplete proficiency-testing records or PT handled differently from patient specimens, and procedure manuals that no longer match actual bench practice are among the recurring themes surveyors and accrediting bodies flag, based on the categories 42 CFR Part 493 explicitly regulates.
What happens if a lab fails its CLIA inspection?
Deficiencies are cited against specific regulatory requirements and generally require a plan of correction, with more serious (condition-level) deficiencies subject to resurvey to confirm the fix. Uncorrected or severe deficiencies — particularly anything posing immediate jeopardy to patient health or safety — can lead to CMS sanctions, up to suspension or revocation of the CLIA certificate.
Is a CLIA survey the same as a CAP inspection?
Not exactly. A Certificate of Accreditation lab is inspected by its accrediting organization (commonly CAP) against that organization’s own standards rather than being directly surveyed by a state agency — but CMS still retains authority to conduct its own validation survey of an accredited lab as a check on the accreditation program.
